Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 264 for infectious diseases

Edit search filters
  1. Analytic Treatment Interruption (ATI) to Assess HIV Cure

    Rochester, MN

  2. Presatovir In Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection Of The Lower Respiratory Tract

    Scottsdale/Phoenix, AZ

  3. An Expanded Access Study Of Sofosbuvir Combined With Ribavirin And Either With Or Without Pegylated Interferon For Treating Aggressive Post-Transplant Hepatitis C

    Jacksonville, FL

  4. SURPASS: A Randomized, Double-Blind, Multicenter Study Of The Efficacy, Safety, And Tolerability Of Brincidofovir Versus Valganciclovir For The Prevention Of Cytomegalovirus (CMV) Disease In CMV Seropositive Kidney Transplant Recipients

    Rochester, MN

  5. A Randomized, Double-Blind, Multicenter, Phase 3 Study Of The Efficacy, Safety, And Tolerability Of Brincidofovir Versus Valganciclovir For The Prevention Of Cytomegalovirus Disease In CMV Seronegative Kidney Allograft Recipients

    Rochester, MN

  6. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection

    Rochester, MN

  7. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection

    Scottsdale/Phoenix, AZ

  8. A Study Of Glecaprevir (GLE)/Pibrentasvir (PIB) In Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 Or 6 Infection And Compensated Cirrhosis

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study of Static versus Articulating Antibiotic Spacer for Periprosthetic Joint Infection in Total Knee Arthroplasty

    Rochester, MN

  10. A Study to Better Understand the Immune Response to the Flu Vaccine (MF59) and the High Dose Flu Vaccine (HDFlu) in People 65 Years of Age and Older

    Rochester, MN

.

Mayo Clinic Footer